Keywords
Medication Adherence
Child
Methylphenidate
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: The study evaluated the adherence to pharmacological treatment of children attended at a specialized child psychiatry outpatient clinic in the interior of Minas Gerais/Brazil. Methods: The descriptive/exploratory study had the sample defined by temporal convenience. Data were collected from October/2020 to March/2022. Semi-structured questionnaires to identify sociodemographic profile and assess psychiatric symptoms in caregivers were applied in the first consultation (pre-pharmacological treatment) and other instruments, to verify medication adherence, were applied 4 and 8 weeks after starting methylphenidate use, respecting the ethical aspects involved in research. Results: Of the 54 research participants, 55.6% were male, 71.4% were between 6 and 9 years old (most from Viçosa-MG), with a predominance of mothers as the main caregiver. The MAT method was applied to 33 patients after 4 weeks with 96.96% adherence and 23 patients after 8 weeks with 95.65% adherence. Conclusion: The sample size was limited, not allowing a significant statistical analysis. A broader study is suggested for a deeper evaluation of medication adherence to methylphenidate.
References
AMERICAN PSYCHIATRIC ASSOCIATION (APA). Manual diagnóstico e estatístico de transtornos mentais: Manual Diagnóstico e Estatístico de Transtornos Mentais (DSM-5). Porto Alegre: Artmed; 2014.
AUSTERMAN J. ADHD and behavioral disorders: Assessment, management, and an update from DSM-5. Cleveland Clinic Journal of Medicine 2015.
BELLÉ AH, et al. Estresse e adaptação psicossocial em mães de crianças com transtorno de déficit de atenção/hiperatividade. Psicologia: Reflexão e Crítica, 2009; 22(3): 317-325.
BENCZIK EBP e CASELLA EB. Compreendendo o impacto do TDAH na dinâmica familiar e as possibilidades de intervenção. Revista Psicopedagogia, 2015; 32(97): 93-103.
BISCEGLI TS, et al. Prevalência de transtorno de déficit de atenção e hiperatividade (TDAH) em pré-escolares de creches. Pediatria Moderna; 2013; 49(8).
BOLANDA H, et al. A literature review and meta-analysis on the effects of ADHD medications on functional outcomes. Journal of Psychiatric Research. 2020; 123: 21–30.
BOND WS, HUSSAR DA. Detection methods and strategies for improving medication compliance. American Journal of Health-System Pharmacy. 1991; 48(9): 1978–88.
BORBA LO, et al. Adaptation and validation of the Measuring of Treatment Adherence for mental health. Revista Brasileira de Enfermagem. 2018; 71(5): 2243–50.
BROTTO AM e GUIMARAES ABP. A influência da família no tratamento de pacientes com doenças crônicas. Psicologia hospital, 2017; 15(1): 43-68.
CHANG Z, et al. Developmental twin study of attention problems: high heritabilities throughout development. JAMA Psychiatry, 2013; 70(3): 311-8.
CONSELHO NACIONAL DE SAÚDE. Resolução n. 466, de 12 de dezembro de 2012. Aprova diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Brasília, Diário oficial da União, 2012.
CONRAD P. The meaning of medications:another look at compliance. Soc Sci Med, 1985; 20(1):29-37.
DELGADO AB e LIMA ML. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psicologia, Saúde & Doenças, 2001; 2(2): 81-100.
DEL BIANCO FARIA AM e CARDOSO CL. Aspectos psicossociais de acompanhantes cuidadores de crianças com câncer: stress e enfrentamento. Estudos de psicologia, 2010; 27(1): 13-20.
DRECHSLER R, et al. ADHD: Current Concepts and Treatments in Children and Adolescents. Neuro pediatrics, 2020; 51(5): 315–35.
FARAONE SV e MICK E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am, 2010; 33(1): 159-80.
FARIA AMB e CARDOSO CL. Estresse em cuidadores de crianças com transtorno do déficit de atenção e hiperatividade. Psico, 2016; 47(3): 228-237.
FRANKE B, et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. European Neuropsycho pharmacology, 2018;28(10):1059–88.
GARDINER P, DVORKIN L. Promoting medication adherence in children. Am Fam Physician, 2006; 74(5): 793-8.
HWANG J-W e BHANG S-Y. 6.20 Factors That Affect the Adherence to Attention-Deficit/Hyperactivity Disorder (ADHD) Medications During a Treatment Continuation Period in Children and Adolescents: A Nationwide Retrospective Cohort Study Using Korean Health Insurance. Journal of the American Academy of Child & Adolescent Psychiatry, 2017; 56(10): S283.
KASHDAN TB, et al. Depression and Anxiety in Parents of Children With ADHD and Varying Levels of Oppositional Defiant Behaviors: Modeling Relationships With Family Functioning. Journal of Clinical Child & Adolescent Psychology, 2004;33(1):169–81.
LEE J. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and hypertension (AASK) pilot study. American Journal of Hypertension,1996;9(8):719–25.
MACHADO MM. Adesão o regime terapêutico: representações das pessoas com IRC sobre o contributo dos enfermeiros. Instituto de educação e Psicologia. Tese de Mestrado, 2009.
MANO GMP, PIERIN AMG. Avaliação de pacientes hipertensos acompanhados pelo Programa Saúde da Família em um Centro de Saúde Escola. Acta Paul. Enferm., 2005; 18(3).
MATTOS P, et al. Apresentação de uma versão em português para uso no Brasil do instrumento MTA-SNAP-IV de avaliação de sintomas de transtorno do déficit de atenção/hiperatividade e sintomas de transtorno desafiador e de oposição. Revista de Psiquiatria do Rio Grande do Sul, 2006; 28(3): 290–7.
MCLOUGHLIN G, et al. Genetic support for the dual nature of attention deficit hyperactivity disorder: substantial genetic overlap between the inattentive and hyperactive-impulsive components. J Abnorm Child Psychol, 2007; 35(6): 999-1008.
MINISTÉRIO DA SAÚDE. Secretaria de Vigilância Sanitária Departamento de Vigilância Sanitária de doenças e agravos não transmissíveis e promoção de saúde. Vigitel Brasil, 2015(1).
O’BRIEN MK, et al. Adherence to Medication Regimens: Updating a Complex Medical Issue. Medical Care Review, 1992; 49(4): 435–54.
OSTERBERG L e BLASCHKE T. Adherence to Medication. New England Journal of Medicine, 2005;353(5):487–97.
PAIS-RIBEIRO JL. Introdução à Psicologia da Saúde, 2007; (2ªed.).
SANTOS AF O, CARDOSO CL. Family members of individuals suffering from mental disorders: Stress and care stressors. Estudos de Psicologia, 2015; 32(1): 87–95.
SHARMA A e COUTURE J. A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD). Annals of Pharmacotherapy, 2013; 48(2): 209–25.
SILVA TFC, et al. Adesão ao tratamento medicamentosoem pacientes do espectro esquizofrênico: uma revisão sistemática da literatura. J Bras Psiquiatria, 2012;61(4):242-51.
TONETTO APM e BARBIERI V. Maternidade de crianças com transtorno de déficit de atenção/hiperatividade: contribuições psicanalíticas. Psicologia Em Estudo, 2018; 23.
VEDANA KGG,et al. Acting for relief:coping with schizophrenia and muisances caused by drug treatment. Ciênc Cuid ,2013;12(2):365-74.
WOLRAICH ML, et al; Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactive Disorder. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics, 2019; 144(4): e20192528.